HealthReveal raises $10.8m led by GE Ventures

HealthReveal, a healthcare technology company that anticipates and mitigates adverse medical events for individuals with chronic disease, has raised $10.8 million of Series A round led by GE Ventures and joined by Greycroft Partners and Flare Capital Partners; Manatt Ventures also had joined the syndicate.

HealthReveal partners with providers, payers and employers to enable them to detect the onset of potentially life threatening health issues and intervene before an adverse event occurs. The company has developed a next generation cloud-based, clinical analytics solution, harnessing the power of evidence-based medicine as a foundation for machine learning.

The HealthReveal solution continually monitors and analyzes patient physiology and care by integrating multiple real-time streams of clinical, operational and biometric data to ensure adherence to evidence-based care guidelines by clinicians and patients. When data suggest that the patient’s care has deviated from those guidelines, HealthReveal suggests immediate and highly personalized interventions to optimize care and reduce the risk of adverse medical events.

“HealthReveal is building an analytical bridge between the medical literature and covered individuals’ phenotypic clinical profiles generating diagnostic and treatment guidance in line with current medical best practice,” said Dr. Lonny Reisman, the company’s CEO and founder. “Our company is founded on the simple principle that knowledge saves lives and that by looking at each patient personally and comprehensively we can make a meaningful improvement in clinical outcomes, medical costs and value.”